To investigate the basis of SOX10’s association with poor patient outcomes, we compared the expression profiles of TNBCs expressing high versus low levels of SOX10 mRNA and found that SOX10high tumours were significantly enriched with the expression of mesenchymal, neural, and glial development genes (Supplementary Fig. 3 and Tables S3, S4). The gene discussed is SOX10; the disease is neoplasm.